Mitchell Lazar is the founder of Flare Therapeutics. Flare Therapeutics has raised $287M in total funding. Latest round: Series C.
Mitchell Lazar is a physician-scientist at the University of Pennsylvania, where he is affiliated with the Department of Medicine and the Smilow Center for Translational Research in Philadelphia. He is a scientific founder of Flare Therapeutics, a company whose approach is based on his seminal work.
Full founder directory · Investor directory · Company funding database · Fundraising library